Skip to main content
. Author manuscript; available in PMC: 2019 Apr 16.
Published in final edited form as: Cardiovasc Toxicol. 2018 Apr;18(2):184–191. doi: 10.1007/s12012-017-9429-8

Table 2.

Drugs causing cardiomyopathy in study group in comparison with their use in the entire group of patients with hematologic malignancies and cardiac ICD codes

Drug used Study group N = 29 Reference group N = 70 All patients N = 820
IMiDs: Thal/Len/Pom 0/2/2 0/4/3 9/42/8
Bortezomib 9 21 51
Carfilzomib 3 3 9
TKIs 3 13 35
Rituximab 10 26 52
Total 29 70 206

IMiDs immunomodulators, Thal thalidomide, Len lenalidomide, Pom pomalidomide, TKIs tyrosine kinase inhibitors